DSM B.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
01 nov 2011 - 08:41
Statutaire naam
DSM B.V.
Titel
DSM reports strong Q3 results
Bericht
Q3 EBITDA from continuing operations €339 million, 26% ahead of Q3 2010
Organic sales growth 14%
Robust performance in Life Sciences despite significant impact of Swiss franc
Very good Materials Sciences results driven by Polymer Intermediates
Martek continued its excellent performance; integration completed
DSM Sinochem Pharmaceuticals joint venture established
EPS (before exceptional items, continuing operations) up 38% to €0.94
Outlook confirmed: 2011 expected to be a strong year
Datum laatste update: 22 februari 2026